Skip to product information
1 of 1
Regular price £193.99 GBP
Regular price £199.95 GBP Sale price £193.99 GBP
Sale Sold out
Free UK Shipping

Freshly Printed - allow 10 days lead

Psychedelic Neuroscience

A multidisciplinary perspective on a popular and controversial topic, this volume addresses the therapeutic potential of psychedelic medicine from the top down (psychology, psychiatry and neurobiology) while explaining its risks and precautionary measures

Tanya Calvey (Edited by)

9780128142554, Elsevier Science

Hardback, published 26 November 2018

261 pages
23.4 x 19 x 2.2 cm, 0.72 kg

We are in the midst of what is being called the ‘psychedelic renaissance’ with growing interest into how psychedelics alter consciousness, brain function and brain connectivity. The acute, often profound, effects of the psychedelic experience can induce lasting improvements in mental health demonstrating that chemistry forms the basis of mystical experience, consciousness and mental wellbeing.

1. An introduction to psychedelic neuroscience Tanya Calvey and Fleur M. Howells 2. The renaissance in psychedelic research: What do preclinical models have to offer Kevin S. Murnane 3. D-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders Danilo De Gregorio, Justine P. Enns, Nicolas A. Nuñez, Luca Posa and Gabriella Gobbi 4. Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition Selen Atasoy, Jakub Vohryzek, Gustavo Deco, Robin L. Carhart-Harris and Morten L. Kringelbach 5. A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder Joseph Barsuglia, Martin Polanco, Robert Palmer, Benjamin Malcolm, Benjamin Kelmendi and Tanya Calvey 6. Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain Felix Müller, Matthias E. Liechti, Undine E. Lang and Stefan Borgwardt 7. Neurocognitive effects of cannabis: Lessons learned from human experimental studies Marco Colizzi and Sagnik Bhattacharyya 8. Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers John Martin Corkery

Subject Areas: Neurosciences [PSAN], Neurology & clinical neurophysiology [MJN], Clinical & internal medicine [MJ]

View full details